ChatDocto
Find a doctor
Metered-dose inhaler

CYVAX 50 µg/25 µg/dose

Salmeterol + Fluticasone · inhalation suspension

FL/120 dosesInhalation
See all pack prices
Strength50 µg/25 µg/dose
Therapeutic classSYSTEME RESPIRATOIRE
ATC codeR03AK06

About this medicine

CYVAX 50 µg/25 µg/dose inhalation suspension is listed in Tunisia's medicine catalog under the active ingredient Salmeterol + Fluticasone. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · FL/120 doses

    Price source not confirmed17,245 DT
    AMM No.
    9283043
    CNAM reference amount
    CNAM status to be confirmed

    Price source: No verified price source is linked to this pack.

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage forminhalation suspension
Route of administrationInhalation
LaboratoryBERG LIFE SCIENCES
OriginGeneric
ScheduleA
ATC codeR03AK06 — Salmétérol et fluticasone
Therapeutic classSYSTEME RESPIRATOIRE

Medicines with matching catalog characteristics

These entries match the recorded ingredient, strength, form and route. This does not establish that they can replace your medicine; confirm any change with a pharmacist.

SERETIDE 50 µg/25 µg/doseSuspension pour inhalationGlaxoSmithKline France · FL/120 doses
Recorded public price62,604 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026